NR1I2 and steatosis: Thus, simultaneous activity at multiple receptors triggering different sub-pathways within the steatosis AOP, for example activation of PXR and inhibition of PPARα, possibly play a key role for the high biological activity of azole compounds with respect to triglyceride accumulation.